Results
10,868 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale | SELL | $27K 76 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $27K 76 sh |
| Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $28K 78 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | McBee BranninChief Development Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $467K 5,182 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $7,137 19 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $14K 39 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $31K 85 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $6,676 18 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $13K 36 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $5,667 15 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $353K 980 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $459K 1,259 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $279K 778 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Frank MalcolmDirector |  FDSFACTSET RESEARCH SYSTEMS INCOpen-market sale | SELL | $308K 1,045 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $510K 1,395 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Armenta AnthonyChief Software & Data Officer |  SERVServe Robotics Inc. /DE/Open-market sale | SELL | $56K 3,893 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 33 | Soule Randy10% Owner |  SAFXXCF Global, Inc.Open-market sale | SELL | $32K 200.0K sh | Jan 14, 2026 traded Jan 9, 2026 |
| 33 | Soule Randy10% Owner | SAFXXCF Global, Inc. Open-market sale | SELL | $31K 200.0K sh | Jan 14, 2026 traded Jan 9, 2026 |
| 33 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $62K 693 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 33 | Soule Randy10% Owner | SAFXXCF Global, Inc. Open-market sale | SELL | $32K 200.0K sh | Jan 14, 2026 traded Jan 9, 2026 |
| 33 | Lo FrancisChief People Officer |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $1.41M 79.6K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 33 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $156K 1,727 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 33 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $129K 1,414 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $215K 584 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $96K 261 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 |  Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner |  ROKUROKU, INCOpen-market sale · 10b5-1 plan | SELL | $1.58M 14.5K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $646K 7,254 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $109K 301 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $116K 316 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $168K 464 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $94K 263 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $93K 253 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $226K 624 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $96K 269 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $646K 7,255 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $87K 247 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $193K 537 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $217K 607 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 31 | Duffy Sean P.Director, Chief Executive Officer |  OMDAOmada Health, Inc.Open-market sale | SELL | $651K 40.8K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 31 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.66M 29.8K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 31 | Elliott Jeffrey ThomasDirector |  QTRXQuanterix CorpGrant or award | A | — 23.4K sh | Jan 14, 2026 traded Jan 2, 2026 |